SpIntellx harnesses the computational power of proprietary unbiased spatial analytics, spatial systems pathology, and explainable artificial intelligence (xAI) to extract information from patient primary disease pathology samples to create predictive knowledge that is required to develop personalized therapeutic strategies, identify potential novel targets for drug discovery, optimally select patient cohorts for clinical trials and improve the predictive power of prognostics/diagnostics.

Biotechnology

SpIntellx

B. Dusty Majumdar

Brian Falkenstein

Maurice Marx

Raymond Yan

A. Burak Tosun

S. Chakra Chennubhotla

Filippo Pullara

Advisors

Machine Learning Team

Leadership Team

Teams at SpIntellx

Advisors

Machine Learning Team

Leadership Team